PURPOSE: To provide a drug composition containing ubidecarenone and useful as a remedy for disease of nose or throat, snivel, stuffing of nose, sneezing, pain of throat and especially snoring.
CONSTITUTION: The objective drug can be prepared by using ubidecarenone as an active component, mixing with diluent, binder, filler, disintegrant, flavor, colorant, lubricant, preservative, etc., and converting to a drug preparation by conventional method. It can be used in the form of tablet, capsule, poultice, vial, powder, granule, troche, solution, suspension, suppository, etc., and administered at a rate of 100W3,000mg per day for an adult of 70kg body-weight in 1W several divided doses. For the suppression of snoring, 2W50mg of the active component is orally administered before going to bed. Ubidecarenone is a lipid existing in mitochondria in a cell, participates in an oxidation- reduction reaction as a component of electron-transfer system conjugated with ATP production and is used as a myocardial metabolism activation agent effective in improving the symptom of congestive heart failure.
Miyao, Kohei
Nishimura, Motoo
